Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of ST-2427 in Healthy Subjects
NCT04475198Phase 1Terminated
- Sponsor
- SiteOne Therapeutics
- Start
- Mar 2021
- Primary completion
- Aug 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of ST-2427 in acute postoperative pain (5 cohorts), sponsored by SiteOne Therapeutics. Primary endpoints: Number of Participants With Treatment-emergent Adverse Events, Number of Participants With Adverse Events Assessed by Blood Pressure and 3 more. Started Mar 2021; status: terminated.
02
Drugs
ST-2427
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on NCT04475198.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04475198.